Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.64 |
| ▸ | PPARA | Q07869 | 5/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.63 |
| ▸ | F7 | P08709 | 4/20 | 0.63 |
| ▸ | F3 | P13726 | 4/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.63 |
| ▸ | PPARD | Q03181 | 3/20 | 0.63 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.63 |
| ▸ | FABP3 | P05413 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.63 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.63 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.63 |
| ▸ | FABP4 | P15090 | 1/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | GNA15 | P30679 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5872449 | 1.00 | PPARG (0.64) | PPARGPPARAALDH1A1F7F3 | |
| SCHEMBL31511872 | 0.97 | PPARG (0.59) | PPARGPPARAALDH1A1F7F3 | |
| SCHEMBL31509285 | 0.92 | PPARG (0.70) | PPARGPPARAALDH1A1F7F3 | |
| SCHEMBL31508786 | 0.92 | PPARG (0.70) | PPARGPPARAALDH1A1F7F3 | |
| SCHEMBL6473220 | 0.92 | PPARG (0.70) | PPARGPPARAALDH1A1F7F3 | |
| SCHEMBL8578185 | 0.92 | PPARG (0.70) | PPARGPPARAALDH1A1F7F3 | |
| SCHEMBL26968801 | 0.86 | PPARG (0.83) | PPARGPPARAF7F3KDM4E | |
| SCHEMBL4924633 | 0.86 | PPARG (0.59) | PPARGPPARAF7F3KDM4E | |
| SCHEMBL17782010 | 0.86 | PPARG (0.59) | PPARGPPARAF7F3KDM4E | |
| SCHEMBL30713149 | 0.86 | PPARG (0.82) | PPARGPPARAALDH1A1F7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4520348-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | Sunforest (Beijing) Biopharma Ltd (CN) | 2025-03-12 | — | — | EP | disclosed |
| CN-115607677-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2023-01-17 | — | — | CN | disclosed |
| CN-114569726-B | Compound for preventing, preventing or treating microbial infection and preparation method and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-10-28 | — | — | CN | disclosed |
| CN-114788872-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-07-26 | — | — | CN | disclosed |
| CN-114569726-A | Compound for preventing, preventing or treating microbial infection and preparation method and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-06-03 | — | — | CN | disclosed |
| US-7101913-B2 | Hepatic disorder suppressant | KAGOME CO., LTD. (JP) | 2006-09-05 | — | — | US | disclosed |
| US-7081480-B2 | Hepatic disorder suppressant | KAGOME CO., LTD. (JP) | 2006-07-25 | — | — | US | disclosed |
| US-20050170027-A1 | Novel hepatic disorder suppressant | ARIMOTO YASUSHI (JP) | 2005-08-04 | — | — | US | disclosed |
| US-20050163877-A1 | Novel hepatic disorder suppressant | ARIMOTO YASUSHI (JP) | 2005-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050163877-A1 | Novel hepatic disorder suppressant | GYS2, OAT, FABP1 | PPARG 2935/4885PPARA 2913/4885ALDH1A1 1021/4885 |
| US-20050170027-A1 | Novel hepatic disorder suppressant | GYS2, OAT, FABP1 | PPARG 2935/4885PPARA 2913/4885ALDH1A1 1021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.